InSightec Ltd., an Israel-based global leader in MR guided Focused Ultrasound Surgery (MRgFUS), has completed a $30.9m Series C financing.
The round includes an investment of $27.6m by GE Healthcare and $3.3m by other investors.
The company intends to use the funding to expand their global reach as well as continuing research and development and clinical studies.
Founded by President and CTO Dr. Jackob (Kobi) Vortman, and led by newly appointed CEO Mr. James (Jim) Davis, and Chairman Tom Gentile, InSightec developed ExAblate, a product which pioneers the use of MRgFUS, and provides a personalized non-invasive treatment that can replace invasive procedures.
InSightec will open US commercial offices in Southeastern Wisconsin, where Jim Davis will be located. The R&D and Operations teams will continue to operate in Israel.